Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Celine Coiffier"'
Autor:
Karina Jawinski, Marcus Hartmann, Charanjit Singh, Ekaterina Kinnear, David C. Busse, Annalisa Ciabattini, Fabio Fiorino, Donata Medaglini, Claudia Maria Trombetta, Emanuele Montomoli, Vanessa Contreras, Roger Le Grand, Celine Coiffier, Charlotte Primard, Bernard Verrier, John S. Tregoning
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Current influenza vaccines manufactured using eggs have considerable limitations, both in terms of scale up production and the potential impact passaging through eggs can have on the antigenicity of the vaccine virus strains. Alternative methods of m
Externí odkaz:
https://doaj.org/article/09463d6bdf634220b38f8e9744e2fabe
Autor:
Celine Coiffier, Bernard Verrier, Didier Gigmes, Thomas Trimaille, Almudena Humanes, Céline Lacroix
Publikováno v:
Pharmaceutical Research
Pharmaceutical Research, American Association of Pharmaceutical Scientists, 2020, 37 (2), ⟨10.1007/s11095-019-2749-6⟩
Pharmaceutical Research, 2020, 37 (2), ⟨10.1007/s11095-019-2749-6⟩
Pharmaceutical Research, American Association of Pharmaceutical Scientists, 2020, 37 (2), ⟨10.1007/s11095-019-2749-6⟩
Pharmaceutical Research, 2020, 37 (2), ⟨10.1007/s11095-019-2749-6⟩
mRNA has recently emerged as a potent therapeutics and requires safe and effective delivery carriers, particularly prone to address its issues of poor stability and escape from endosomes. In this context, we designed poly(D,L-lactide) (PLA)-based mic
Autor:
Myriam Lamrayah, Capucine Phelip, Renaud Rovera, Céline Coiffier, Nora Lazhar, Francesca Bartolomei, Evelyne Colomb, Bernard Verrier, Claire Monge, Sophie Richard
Publikováno v:
Molecules, Vol 28, Iss 12, p 4778 (2023)
Vaccine technology is still facing challenges regarding some infectious diseases, which can be addressed by innovative drug delivery systems. In particular, nanoparticle-based vaccines combined with new types of adjuvants are actively explored as a p
Externí odkaz:
https://doaj.org/article/601750c1bcdc4bf1b906f54f5d3a6a08
Autor:
Altan Yavuz, Céline Coiffier, Cynthia Garapon, Serra Gurcan, Claire Monge, Jean-Yves Exposito, Danielle Campiol Arruda, Bernard Verrier
Publikováno v:
Pharmaceutics, Vol 15, Iss 3, p 1009 (2023)
mRNA-based vaccines have made a leap forward since the SARS-CoV-2 pandemic and are currently used to develop anti-infectious therapies. If the selection of a delivery system and an optimized mRNA sequence are two key factors to reach in vivo efficacy
Externí odkaz:
https://doaj.org/article/c4ef96cf967145409fbecaf0fe7b35dd
Autor:
Alexia Giraud, Yasemin Ataman-Önal, Andrea Babic-Erceg, F. Biron, Celine Coiffier, Bernard Verrier
Publikováno v:
AIDS Res Hum Retroviruses
AIDS Res Hum Retroviruses, 1999, 15, pp.1035-1039
AIDS Res Hum Retroviruses, 1999, 15, pp.1035-1039
PRIM A RY HIV-1 INFEC TIO N is characterized by a burst of viral replication that occurs 2 to 6 weeks after the transmission of the virus. In 30–90% of newly infected individuals, virus dissemination can cause clinical manifestations of varying sev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdcfc551daf022b20757676616849dc8
https://hal.archives-ouvertes.fr/hal-00315035
https://hal.archives-ouvertes.fr/hal-00315035
Autor:
Myriam Lamrayah, Capucine Phelip, Céline Coiffier, Céline Lacroix, Thibaut Willemin, Thomas Trimaille, Bernard Verrier
Publikováno v:
Pharmaceutics, Vol 14, Iss 1, p 107 (2022)
Micelles from amphiphilic polylactide-block-poly(N-acryloxysuccinimide-co-N-vinylpyrrolidone) (PLA-b-P(NAS-co-NVP)) block copolymers of 105 nm in size were characterized and evaluated in a vaccine context. The micelles were non-toxic in vitro (both i
Externí odkaz:
https://doaj.org/article/b5ed600d0a6a4b909f06d08b0af53588